Hot Features
Ondine Biomedical Inc., a life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally. Its primary product is Steriwave, which enables rapid elimination of pathogens associated with healthcare-associated infections. In addition, th... Ondine Biomedical Inc., a life-sciences company, engages in the development and commercialization of antimicrobial therapies in Canada and internationally. Its primary product is Steriwave, which enables rapid elimination of pathogens associated with healthcare-associated infections. In addition, the company offers a pipeline of products for various indications, including burns, ventilator tube, and sinus; and serious and chronic wounds, chronic sinusitis, ventilator-associated pneumonia VAP, and central line bloodstream infections, as well as catheter-associated urinary tract infection. Ondine Biomedical Inc. was incorporated in 1996 and is headquartered in Vancouver, Canada. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 1.5 | 11.5384615385 | 13 | 14.75 | 12.75 | 461776 | 13.86306597 | DE |
| 4 | -0.5 | -3.33333333333 | 15 | 15.5 | 12.75 | 425312 | 14.18989506 | DE |
| 12 | 3.75 | 34.8837209302 | 10.75 | 15.5 | 10.45 | 482642 | 12.8323506 | DE |
| 26 | 4 | 38.0952380952 | 10.5 | 15.5 | 8 | 339109 | 11.55453485 | DE |
| 52 | 4 | 38.0952380952 | 10.5 | 18.25 | 8 | 312627 | 12.77946723 | DE |
| 156 | -1 | -6.45161290323 | 15.5 | 18.25 | 4.5 | 267801 | 10.56961066 | DE |
| 260 | -41.5 | -74.1071428571 | 56 | 59 | 4.5 | 196219 | 13.19415787 | DE |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.